Latest Headlines

Latest Headlines

J&J, Pfizer in tug-of-war over ads for Infants' Advil

Back in 1989, a court order limited advertising claims for Advil, now owned by Pfizer. But does that order extend to Infants' Advil, which didn't exist at the time? Rival Johnson & Johnson says yes--and it's forced Pfizer to pull one of its ads for that very reason.

The Battered Brand: A Tylenol Recall Timeline

George Miller and Erica Teichert It's been rough sledding for Tylenol the past few years. The once shiny brand was first marketed by Robert McNeil Jr. in 1955, in a red box shaped like a fire truck

Records audit prompts Tylenol, Rolaids recalls

It's death by a thousand cuts: Another Tylenol recall follows continued digging by McNeil into records documenting production prior to last April's manufacturing suspension at its Fort Washington,

J&J gets lots of play in pundit look-backs

According to CNBC money madman Jim Cramer, the best way for Johnson & Johnson ($JNJ) to restore credibility among consumers and maintain value for investors is by getting rid of CEO Bill Weldon (

Group calls on FDA for objective Tylenol investigation

The FDA should ensure a "complete and objective" scientific investigation into the musty-odor Tylenol recalls and then publicize the results, says the nonprofit Institute for Safe Medication

Consent decree trumps prosecution in some cases

Last week's J&J/McNeil recall of Tylenol caplets marks its 13th in just over a year. That's enough for Donald Riker, president at healthcare industry consultancy On Point Advisors. Riker, using

J&J: Another recall, another earnings rise

Tuesday's Johnson & Johnson/McNeil recall of Tylenol 8-hour caplets is an unremarkable data point in the company's continuing quality-meltdown saga. It's on the small end of Tylenol recalls at

Congress clips smoking e-mails to Weldon invite

The news that Colleen Goggins will retire as J&J's consumer group head, announced last Thursday, has proven a real headline-grabber, as well as a cautionary tale about the dangers of prioritizing

States set sights on J&J for Tylenol recalls

Attorneys general from several states have joined the line of those requesting documents from Johnson & Johnson regarding recent Tylenol recalls. The Wall Street Journal reports that "multiple"

Private labeler Activis revs up for Tylenol shortfall

Private-label drugmaker Activis says it has boosted manufacturing capacity five-fold to meet retailer demand for pain relievers following the Tylenol recalls. Among those retailers are big guns CVS,